Literature DB >> 29364511

[18 F]GE180 positron emission tomographic imaging indicates a potential double-hit insult in the intrahippocampal kainate mouse model of temporal lobe epilepsy.

Mirjam Brackhan1,2, Pablo Bascuñana1, Tobias L Ross1, Frank M Bengel1, Jens P Bankstahl1, Marion Bankstahl2.   

Abstract

OBJECTIVE: Accumulating evidence suggests that brain inflammation, elicited by epileptogenic insults, is involved in epilepsy development. Noninvasive nuclear imaging of brain inflammation in animal models of epileptogenesis represents a diagnostic in vivo approach with potential for direct translation into the clinic. Here, we investigated up-regulation of the translocator protein (TSPO) indicative of microglial activation by serial [18 F]GE180 positron emission tomographic (PET) imaging in a mouse model of temporal lobe epilepsy.
METHODS: As epileptogenic insult, a status epilepticus (SE) was induced in mice by intrahippocampal injection of kainate. Post-SE mice injected with kainate and sham-injected mice were subjected to [18 F]GE180 PET scans before SE and at 2 days, 5-7 days, 2 weeks, 3 weeks, 7 weeks, and 14 weeks postinsult. For data evaluation, brain regions ipsilateral and contralateral to the injection site were outlined by coregistration with a standard mouse brain atlas, and percentage of injected dose per cubic centimeter was calculated. In addition, a statistical parametric mapping analysis, comparing post-SE mice to baseline, sham mice to baseline, and post-SE to sham mice was performed.
RESULTS: Following SE, elevations in [18 F]GE180 uptake were most prominent in the ipsilateral hippocampus, occurring between 2 days and at least 7 weeks after SE, with a peak at 5-7 days after SE. In the contralateral hippocampus and other epilepsy-associated brain regions, increased tracer uptake was observed with a similar time profile but to a lesser extent. Moderate enhancement of tracer uptake was also evident in mice after sham surgery. SIGNIFICANCE: TSPO in vivo imaging reliably detects brain inflammation during epileptogenesis. These inflammatory processes most prominently affect the hippocampus ipsilateral to the injection site. Inflammation induced by the traumatic insult associated with surgery synergistically contributes to total brain inflammation and may also contribute to epileptogenesis. The revealed time course of neuroinflammation will help to identify appropriate time points for anti-inflammatory, potentially antiepileptogenic treatment. Wiley Periodicals, Inc.
© 2018 International League Against Epilepsy.

Entities:  

Keywords:  activated microglia; neuroinflammation; positron emission tomography biomarker; translocator protein

Mesh:

Substances:

Year:  2018        PMID: 29364511     DOI: 10.1111/epi.14009

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein.

Authors:  Leah P Dickstein; Jeih-San Liow; Alison Austermuehle; Sami Zoghbi; Sara K Inati; Kareem Zaghloul; Paolo Zanotti-Fregonara; William H Theodore
Journal:  Epilepsia       Date:  2019-05-30       Impact factor: 5.864

2.  [18F]DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus.

Authors:  Ken-Ichi Kaneko; Satsuki Irie; Aya Mawatari; Ami Igesaka; Di Hu; Takayoshi Nakaoka; Emi Hayashinaka; Yasuhiro Wada; Hisashi Doi; Yasuyoshi Watanabe; Yilong Cui
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-14       Impact factor: 10.057

Review 3.  Identification of clinically relevant biomarkers of epileptogenesis - a strategic roadmap.

Authors:  Michele Simonato; Denes V Agoston; Amy Brooks-Kayal; Chris Dulla; Brandy Fureman; David C Henshall; Asla Pitkänen; William H Theodore; Roy E Twyman; Firas H Kobeissy; Kevin K Wang; Vicky Whittemore; Karen S Wilcox
Journal:  Nat Rev Neurol       Date:  2021-02-16       Impact factor: 42.937

4.  Clinical evaluation of neuroinflammation in child-onset focal epilepsy: a translocator protein PET study.

Authors:  Kuriko Kagitani-Shimono; Hiroki Kato; Ryoko Kuwayama; Koji Tominaga; Shin Nabatame; Haruhiko Kishima; Jun Hatazawa; Masako Taniike
Journal:  J Neuroinflammation       Date:  2021-01-06       Impact factor: 8.322

5.  Reduced Acquisition Time [18F]GE-180 PET Scanning Protocol Replaces Gold-Standard Dynamic Acquisition in a Mouse Ischemic Stroke Model.

Authors:  Artem Zatcepin; Steffanie Heindl; Ulrike Schillinger; Lena Kaiser; Simon Lindner; Peter Bartenstein; Anna Kopczak; Arthur Liesz; Matthias Brendel; Sibylle I Ziegler
Journal:  Front Med (Lausanne)       Date:  2022-02-10

6.  Exploring with [18F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy.

Authors:  Robrecht Raedt; Alain Plenevaux; Maria Elisa Serrano; Mohamed Ali Bahri; Guillaume Becker; Alain Seret; Charlotte Germonpré; Christian Lemaire; Fabrice Giacomelli; Frédéric Mievis; André Luxen; Eric Salmon; Bernard Rogister
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

Review 7.  Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Chin J Traumatol       Date:  2018-04-24

8.  TSPO PET Identifies Different Anti-inflammatory Minocycline Treatment Response in Two Rodent Models of Epileptogenesis.

Authors:  Bettina J Wolf; Mirjam Brackhan; Jens P Bankstahl; Marion Bankstahl; Pablo Bascuñana; Ina Leiter; B Laura N Langer; Tobias L Ross
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

Review 9.  Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.

Authors:  Pablo Bascuñana; Luisa Möhle; Mirjam Brackhan; Jens Pahnke
Journal:  Drugs R D       Date:  2020-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.